Back to results
US 2025/0376540 A1Published application
Binding Proteins 1
AssigneesNucleus Therapeutics Pty. Ltd, Yale University
InventorsJames Campbell, Valentina Dubljevic, James Hansen, Zahra Rattray, Jiangbing Zhou
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to cell penetrating anti-DNA binding proteins. Compositions comprising these binding proteins may be may be useful for delivering agents to cells and treating diseases such as cancer.
Claims23
A cell penetrating anti-DNA binding protein having an antigen binding domain, wherein the antigen binding domain binds to DNA and comprises:
- a heavy chain variable region (Vu) comprising a sequence as shown in any one of SEQ ID NOs:
- 17 to 23 and light chain variable region (Vt) comprising a sequence as shown in any one of SEQ ID NOs:
- 24 to 29.
-6. (canceled)
-12. (canceled)
(canceled)
-20. (canceled)
-31. (canceled)
Dependencies are inferred from the claim text.